News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Joint Announcement Regarding The Intended Consensual Termination Of The Transaction Implementation Agreement ("TIA") Between Adcock Ingram And CFR Pharmaceuticals ("The Parties")


2/7/2014 9:19:59 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SANTIAGO, Chile, Feb. 7, 2014 (GLOBE NEWSWIRE) -- CFR Pharmaceuticals S.A. (SSE: CFR), the Chilean multinational emerging markets pharmaceutical company, leader in specialties and prescription medicines, refers shareholders to the announcements released on the Stock Exchange News Service ("SENS") of the JSE Limited by Adcock Ingram Holdings Limited ("Adcock") and by The Bidvest Group Limited ("Bidvest") on Friday, 31 January 2014, regarding the acquisition by a consortium comprising Bidvest and Community Investment Holdings (Pty) Limited of approximately 34.5% of the ordinary issued share capital of Adcock.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES